Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by mercedesmanon Jul 05, 2023 10:09am
264 Views
Post# 35527165

Did the pace of enrollment …

Did the pace of enrollment …

...potential, just increase by 20% ? ( 3/15 sites)

Will the potential enrollment rate have increased by 33% ( 5/15 sites) by the end of this month? 

Where are the FUD dummies that said it would take 2, 3, 4+ years to get to 90 and 7 years to achieve 150? 

Possible Pathway to 90 from 65 BEFORE YEAR END : 

july +3. cumm. 68
aug +4. cumm 72
sept +5 cumm 77
oct +5  cumm. 82
nov + 6 cumm 88

Personally I am hoping for the release of some raw mortality stats at that time (interim data release) that might enable investors ( but at the very least Baxter) to statistically gauge the odds of ultimate FDA approval in this  OPEN LABEL, BAYESIAN, CONFIRMATORY, 3B RCT TRIAL with a 28 DAY MORTALITY PRIMARY END POINT, clearing the pathway to a minimum of a $2BILLION USD market ( more likely $3-$5 B IMO) 

MM 

PS I will, of course, be accused of being a shill, but numbers and stats and trends don't lie... like FUD workers do. 
 

<< Previous
Bullboard Posts
Next >>